| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4045496
[patent_doc_number] => 05874546
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Fas antigen'
[patent_app_type] => 1
[patent_app_number] => 8/219237
[patent_app_country] => US
[patent_app_date] => 1994-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 11620
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874546.pdf
[firstpage_image] =>[orig_patent_app_number] => 219237
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/219237 | Fas antigen | Mar 27, 1994 | Issued |
Array
(
[id] => 3722581
[patent_doc_number] => 05672513
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'Carcino-embryonic antigen derivatives lacking the carboxyl terminal end'
[patent_app_type] => 1
[patent_app_number] => 8/217299
[patent_app_country] => US
[patent_app_date] => 1994-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8238
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672513.pdf
[firstpage_image] =>[orig_patent_app_number] => 217299
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/217299 | Carcino-embryonic antigen derivatives lacking the carboxyl terminal end | Mar 22, 1994 | Issued |
Array
(
[id] => 3872927
[patent_doc_number] => 05804193
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Truncated PSPA lacking a functional cell membrane anchor region'
[patent_app_type] => 1
[patent_app_number] => 8/214222
[patent_app_country] => US
[patent_app_date] => 1994-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 7421
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804193.pdf
[firstpage_image] =>[orig_patent_app_number] => 214222
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/214222 | Truncated PSPA lacking a functional cell membrane anchor region | Mar 16, 1994 | Issued |
Array
(
[id] => 4055760
[patent_doc_number] => 05863742
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-26
[patent_title] => 'Inhibition of protease activity of human whole blood cell lysates'
[patent_app_type] => 1
[patent_app_number] => 8/212442
[patent_app_country] => US
[patent_app_date] => 1994-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6693
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/863/05863742.pdf
[firstpage_image] =>[orig_patent_app_number] => 212442
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/212442 | Inhibition of protease activity of human whole blood cell lysates | Mar 9, 1994 | Issued |
Array
(
[id] => 3471736
[patent_doc_number] => 05476778
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-19
[patent_title] => 'Method of growing and attenuating a viral agent associated with mystery swine disease'
[patent_app_type] => 1
[patent_app_number] => 8/207563
[patent_app_country] => US
[patent_app_date] => 1994-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3508
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/476/05476778.pdf
[firstpage_image] =>[orig_patent_app_number] => 207563
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/207563 | Method of growing and attenuating a viral agent associated with mystery swine disease | Mar 6, 1994 | Issued |
Array
(
[id] => 3458042
[patent_doc_number] => 05468486
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-21
[patent_title] => 'Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis'
[patent_app_type] => 1
[patent_app_number] => 8/205194
[patent_app_country] => US
[patent_app_date] => 1994-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2263
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/468/05468486.pdf
[firstpage_image] =>[orig_patent_app_number] => 205194
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/205194 | Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis | Mar 2, 1994 | Issued |
Array
(
[id] => 3730034
[patent_doc_number] => 05665566
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Cloning of enterokinase and method of use'
[patent_app_type] => 1
[patent_app_number] => 8/200900
[patent_app_country] => US
[patent_app_date] => 1994-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11960
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665566.pdf
[firstpage_image] =>[orig_patent_app_number] => 200900
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/200900 | Cloning of enterokinase and method of use | Feb 22, 1994 | Issued |
| 08/195730 | NOVEL MAMMALIAN CELL CYCLE PROTEIN | Feb 13, 1994 | Abandoned |
Array
(
[id] => 3844991
[patent_doc_number] => 05718903
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-17
[patent_title] => 'Vaccine comprising Brucella abortus which has O polysaccharide antigen absent'
[patent_app_type] => 1
[patent_app_number] => 8/196777
[patent_app_country] => US
[patent_app_date] => 1994-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16516
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/718/05718903.pdf
[firstpage_image] =>[orig_patent_app_number] => 196777
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/196777 | Vaccine comprising Brucella abortus which has O polysaccharide antigen absent | Feb 13, 1994 | Issued |
Array
(
[id] => 4029611
[patent_doc_number] => 05855902
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Method of administering a vaccine comprising tritrichomonas foetus membrane surface antigens between 45 and 300 kilopaltons'
[patent_app_type] => 1
[patent_app_number] => 8/192807
[patent_app_country] => US
[patent_app_date] => 1994-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9507
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/855/05855902.pdf
[firstpage_image] =>[orig_patent_app_number] => 192807
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/192807 | Method of administering a vaccine comprising tritrichomonas foetus membrane surface antigens between 45 and 300 kilopaltons | Feb 6, 1994 | Issued |
Array
(
[id] => 3730385
[patent_doc_number] => 05703213
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Monoclonal antibodies which recognize an adenocarcinoma cell antigen'
[patent_app_type] => 1
[patent_app_number] => 8/193673
[patent_app_country] => US
[patent_app_date] => 1994-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 19505
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/703/05703213.pdf
[firstpage_image] =>[orig_patent_app_number] => 193673
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/193673 | Monoclonal antibodies which recognize an adenocarcinoma cell antigen | Feb 6, 1994 | Issued |
Array
(
[id] => 3831465
[patent_doc_number] => 05739272
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Procedure for obtaining carbocalcitonin'
[patent_app_type] => 1
[patent_app_number] => 8/193755
[patent_app_country] => US
[patent_app_date] => 1994-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7040
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739272.pdf
[firstpage_image] =>[orig_patent_app_number] => 193755
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/193755 | Procedure for obtaining carbocalcitonin | Feb 2, 1994 | Issued |
| 08/191352 | DNA ENCODING INTESTINAL TREFOIL PROTEINS | Feb 1, 1994 | Pending |
| 08/185738 | P53 VACCINE | Jan 23, 1994 | Abandoned |
| 08/185216 | SCHIZOSACCHAROMYCES - SPECIFIC POLYPEPTIDES | Jan 23, 1994 | Abandoned |
| 08/179106 | HERPESVIRUS REPLICATION DEFECTIVE MUTANTS | Jan 9, 1994 | Abandoned |
| 08/178055 | SOFT AGAR PENETRATION-DEFECTIVE MUTANTS | Jan 5, 1994 | Abandoned |
Array
(
[id] => 3876341
[patent_doc_number] => 05728578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-17
[patent_title] => 'Peptide of the structural phosphoprotein (pp 150) of human cytomegalovirus, and DNA encoding said peptide'
[patent_app_type] => 1
[patent_app_number] => 8/159710
[patent_app_country] => US
[patent_app_date] => 1993-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1274
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/728/05728578.pdf
[firstpage_image] =>[orig_patent_app_number] => 159710
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/159710 | Peptide of the structural phosphoprotein (pp 150) of human cytomegalovirus, and DNA encoding said peptide | Nov 30, 1993 | Issued |
Array
(
[id] => 3872956
[patent_doc_number] => 05804195
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Vaccine comprising an infectious bursal disease virus MB, MB-1 or MB-2 strain'
[patent_app_type] => 1
[patent_app_number] => 8/159424
[patent_app_country] => US
[patent_app_date] => 1993-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4514
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804195.pdf
[firstpage_image] =>[orig_patent_app_number] => 159424
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/159424 | Vaccine comprising an infectious bursal disease virus MB, MB-1 or MB-2 strain | Nov 29, 1993 | Issued |
Array
(
[id] => 3811662
[patent_doc_number] => 05710014
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-20
[patent_title] => 'Cloned cDNA for human procathepsin l.'
[patent_app_type] => 1
[patent_app_number] => 8/158075
[patent_app_country] => US
[patent_app_date] => 1993-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 2847
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/710/05710014.pdf
[firstpage_image] =>[orig_patent_app_number] => 158075
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/158075 | Cloned cDNA for human procathepsin l. | Nov 23, 1993 | Issued |